Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Previous article
Next article
Original Communication

Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD)

Published Online:April 24, 2019https://doi.org/10.1024/0300-9831/a000568

Abstract

Abstract. In an attempt to investigate new strategies aimed at reducing risk factors of non-alcoholic fatty liver disease (NAFLD), effects of turmeric (Curcuma longa L.) and chicory seed (Cichorium intybus L.) supplementation was evaluated in these patients. In this double-blind, randomized, controlled clinical trial, 92 patients with NAFLD aged 20–60 year with body mass index (BMI) ranged 24.9–40 kg/m2 was randomly assigned to 4 groups as follows. 1) Turmeric supplementation (3 g/d) (n = 23, TUR); 2) Chicory seed supplementation (infused 9 g/d (4.5 g /100mL)) (n = 23, CHI); 3) Turmeric and chicory seed supplementation (3 g/d turmeric + infused 9 g/d chicory seed (n = 23, TUR + CHI); 4) Placebo (n = 23, PLA). All intervention periods were 12 weeks. Fasting blood samples, anthropometric measurements, dietary records and physical activity were collected at baseline and at the end of the trial. Significant decreases were observed in BMI and waist circumference (WC) of subjects in CHI and TUR + CHI groups, compared with PLA group (p < 0.05). Combination of turmeric and chicory seed significantly decreased serum alkaline phosphatase level (p < 0.05). Serum levels of HDL-C increased considerably in TUR and TUR + CHI groups (p < 0.05 vs. placebo). Turmeric supplementation alone and plus chicory seed led to significant reduction in serum levels of TG/HDL-C and LDL-C/HDL-C ratio in TUR and TUR + CHI groups in comparison with placebo (p < 0.05). In conclusion, turmeric and chicory seed supplementation can be significantly useful in management of NAFLD risk factors.

References

  • 1 Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., Charlton, M., & Sanyal, A.J. (2012) The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 55(6), 2005–2023. First citation in articleCrossref Medline, Google Scholar

  • 2 Chitturi, S., Wong, V.W., & Farrell, G. (2011) Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. J. Gastroenterol. Hepatol. 26(s1), 163–172. First citation in articleCrossref Medline, Google Scholar

  • 3 Rafiq, N., & Younossi, Z.M. (2009) Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin. Liver. Dis. 13(2), 249–266. First citation in articleCrossref Medline, Google Scholar

  • 4 Clark, J.M., Brancati, F.L., & Diehl, A.M. (2002) Nonalcoholic fatty liver disease. Gastroenterology. 122(6), 1649–1657. First citation in articleCrossref Medline, Google Scholar

  • 5 Videla, L.A., Rodrigo, R., Araya, J., & Poniachik, J. (2006) Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends. Mol. Med. 12(12), 555–558. First citation in articleCrossref Medline, Google Scholar

  • 6 Valenzuela, R., & Videla, L.A. (2011) The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food. Funct. 2(11), 644–648. First citation in articleCrossref Medline, Google Scholar

  • 7 Erickson, S.K. (2009) Nonalcoholic fatty liver disease. J. Lipid. Res. S412–S416. First citation in articleGoogle Scholar

  • 8 Del Prete, A., Scalera, A., Iadevaia, M.D., Miranda, A., Zulli, C., Gaeta, L., Tuccillo, C., Federico, A., & Loguercio, C. (2012) Herbal products: benefits, limits, and applications in chronic liver disease. Evid. Based. Complement. Alternat. Med. 2012, 837939. First citation in articleCrossref Medline, Google Scholar

  • 9 Stickel, F., & Schuppan, D. (2007) Herbal medicine in the treatment of liver diseases. Dig. Liver. Dis. 39(4), 293–304. First citation in articleCrossref Medline, Google Scholar

  • 10 Robert, C.G.M., Harini, S.A., Daniel, M., & Yan, Li. (2012) Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects. Food. Chem. Toxicol. 50(2), 227–231. First citation in articleCrossref Medline, Google Scholar

  • 11 George, B.O., Abbi, O.G., & Eboh, O. (2015) The protective effect of aqueous extract of turmeric (Curcuma longa) on Cycas induced oxidative stress. A. J. A. S. T. 3, 398–406. First citation in articleGoogle Scholar

  • 12 Chi-Ho, L., Ah-Young, K., Chang-Won, P., Michihiro, F., & Kyu-Ho, H. (2014) Turmeric (Curcuma longa) whole powder reduces accumulation of visceral fat mass and increases hepatic oxidative stress in rats fed a high-fat diet. Food. Sci. Biotechnol. 23(1), 261–267. First citation in articleCrossref, Google Scholar

  • 13 Ramírez-Tortosa, M.C., Mesa, M.D., Aguilera, M.C., Quilesm, J.L., Baró, L., Ramirez-Tortosa, C.L., Martinez-Victoria, E., & Gil, A. (1999) Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis. 147(2), 371–378. First citation in articleCrossref Medline, Google Scholar

  • 14 Kim, S.W., Ha, K.C., Choi, E.K., Jung, S.Y., Kim, M.G., Kwon, D.Y., Yang, H.J., Kim, M.J., Kang, H.J., & Back, H.I. (2013) The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study. BMC Complement. Altern Med. 13(1), 1. First citation in articleCrossref Medline, Google Scholar

  • 15 Renée, A.S., Jasmeen, S., & Gerhard, P. (2013) Cichorium intybus: Traditional uses, phytochemistry, pharmacology, and toxicology. Evid. Based. Complement. Alternat. Med. 579319. First citation in articleGoogle Scholar

  • 16 Ghamarian, A., Abdollahi, M., Su, X., Amiri, A., Ahadi, A., & Nowrouzi, A. (2012) Effect of chicory seed extract on glucose tolerance test (GTT) and metabolic profile in early and late stage diabetic rats. Daru. 20(1), 56. First citation in articleCrossref Medline, Google Scholar

  • 17 Cho, A.S., Jeon, S.M., Kim, M.J., Yeo, J., Seo, K.I., Choi, M.S., & Lee, M.K. (2010) Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food. Chem. Toxicol. 48(3), 937–943. First citation in articleCrossref Medline, Google Scholar

  • 18 Karthikesan, K., Pari, L., & Menon, V.P. (2010) Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. Gen. Physiol. Biophys. 29(1), 23–30. First citation in articleCrossref Medline, Google Scholar

  • 19 Sanyal, A.J. (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 123(5), 1705–25. First citation in articleCrossref Medline, Google Scholar

  • 20 Silva-Batista, C., Urso, R.P., Lima Silva, A.E., & Bertuzzi, R. (2013) Associations Between Fitness Tests and the International Physical Activity Questionnaire – Short Form in Healthy Men. J. Strength. Cond. Res. 27(12), 3481–3487. First citation in articleCrossref Medline, Google Scholar

  • 21 Friedewald, W.T., Levy, R.I., & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499–502. First citation in articleCrossref Medline, Google Scholar

  • 22 Dobiásová, M., & Frohlich, J. (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FER(HDL)). Clin. Biochem. 34(7), 583–588. First citation in articleCrossref Medline, Google Scholar

  • 23 Ejaz, A., Wu, D., Kwan, P., & Meydani, M. (2009) Curcumin inhibits adipogenesis in 3T3–L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr. 139(5), 919–925. First citation in articleCrossref Medline, Google Scholar

  • 24 Kim, J.G., Mandal, P.K., Choi, K.D., Pyun, C.W., Hong, G.E., & Lee, C.H. (2014) Beneficial dietary effect of turmeric and sulphur on weight gain, fat deposition and lipid profile of serum and liver in rats. J. Food. Sci. Technol. 51(4), 774–779. First citation in articleCrossref Medline, Google Scholar

  • 25 Wang, S., Wang, X., Ye, Z., Xu, C., Zhang, M., Ruan, B., Wei, M., Jiang, Y., Zhang, Y., & Wang, L. (2015) Curcumin promotes browning of white adipose tissue in a norepinephrine-dependent way. Biochem. Biophys. Res. Commun. 466(2), 247–253. First citation in articleCrossref Medline, Google Scholar

  • 26 Arafa, H.M. (2005) Curcumin attenuates diet-induced hypercholesterolemia in rats. Med. Sci. Monit. 11(7), BR228–BR234. First citation in articleMedline, Google Scholar

  • 27 Begum, A.N., Jones, M.R., Lim, G.P., Morihara, T., Kim, P., Heath, D.D., Rock, C.L., Pruitt, M.A., Yang, F., & Hudspeth, B. (2008) Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J. Pharmacol. Exp. Ther. 326(1), 196–208. First citation in articleCrossref Medline, Google Scholar

  • 28 Xiao, H., Xie, G., Wang, J., Hou, X., Wang, X., Wu, W., & Liu, X. (2013) Chicoric acid prevents obesity by attenuating hepatic steatosis, inflammation and oxidative stress in high-fat diet-fed mice. Food. Res. Int. 54(1), 345–353. First citation in articleCrossref, Google Scholar

  • 29 Ahmed, B., Al-Howiriny, T.A., & Siddiqui, A.B. (2003) Antihepatotoxic activity of seeds of Cichorium intybus. J. Ethnopharmacol. 87(2), 237–240. First citation in articleCrossref Medline, Google Scholar

  • 30 Na, L.X., Li, Y., Pan, H.Z., Zhou, X.L., Sun, D.J., Meng, M., Li, X.X., & Sun, C.H. (2013) Curcuminoids exert glucose‐lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double‐blind, placebo‐controlled trial. Mol. Nutr. Food. Res. 57(9), 1569–1577. First citation in articleCrossref Medline, Google Scholar

  • 31 Öner-İyidoğan, Y., Koçak, H., Seyidhanoğlu, M., Gürdöl, F., Gülçubuk, A., Yildirim, F., Çevik, A., & Uysal, M. (2013) Curcumin prevents liver fat accumulation and serum fetuin – A increase in rats fed a high-fat diet. J. Physiol. Biochem. 69(4), 677–686. First citation in articleCrossref Medline, Google Scholar

  • 32 Hyder, M.A., Hasan, M., & Mohieldein, A.H. (2013) Comparative levels of ALT, AST, ALP and GGT in liver associated diseases. Eur. J. Exp. Biol. 3(2), 280–284. First citation in articleGoogle Scholar

  • 33 Naseem, N. (2011) Effects of the Aqueous and Alcoholic Extracts of Seeds of Cichorium Intybus Linn (Kasni) In Treatment of Liver Damaged By Carbon Tetrachloride (CCl4). Ann. Pak. Inst. Med. Sci. 7(4), 200–203. First citation in articleGoogle Scholar

  • 34 Rivera-Espinoza, Y., & Muriel, P. (2009) Pharmacological actions of curcumin in liver diseases or damage. Liver. Int. 29(10), 1457–1466. First citation in articleCrossref Medline, Google Scholar

  • 35 Chuengsamarn, S., Rattanamongkolgul, S., Phonrat, B., Tungtrongchitr, R., & Jirawatnotai, S. (2014) Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J. Nutr. Biochem. 25(2), 144–150. First citation in articleCrossref Medline, Google Scholar

  • 36 Selvi, N.M.K., Sridhar, M., Swaminathan, R., & Sripradha, R. (2015) Efficacy of Turmeric as Adjuvant Therapy in Type 2 Diabetic Patients. Indian. J. Clin. Biochem. 30(2), 180–186. First citation in articleCrossref Medline, Google Scholar

  • 37 Sahebkar, A. (2014) A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin. Nutr. 33(3), 406–414. First citation in articleCrossref Medline, Google Scholar

  • 38 Katiyar, P., Kumar, A., Mishra, A.K., Dixit, R.K., & Gupta, A.K. (2015) Evaluating hypolipidemic potential of kasni seed (Cichorium intybus) preparations in newly diagnosed patients of metabolic disorder. I. J. P. S. R. 6(9), 4092. First citation in articleGoogle Scholar

  • 39 Rub, R.A., Siddiqui, A., Ali, A.M., Shaikh, A., & Mukadam, M. (2014) Screening of Antioxidant & Antidiabetic Potential of Polyphenol rich fraction from Cichorium intybus. Pharmacogn. J. 6(4), 92–98. First citation in articleCrossref, Google Scholar

  • 40 Hernandez-Rodas, M.C., Valenzuela, R., & Videla, L.A. (2015) Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. Int. J. Mol. Sci. 16, 25168–25198. First citation in articleCrossref Medline, Google Scholar

  • 41 Sofi, F., & Casini, A. (2014) Mediterranean diet and non-alcoholic fatty liver disease: New therapeutic option around the corner? World J. Gastroenterol. 20(23), 7339–7346. First citation in articleCrossref Medline, Google Scholar